Search filters

List of works by Kenichi Morikawa

A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma.

scientific article

Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.

scientific article

Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.

scientific article published on 10 February 2018

Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people

scientific article published on 23 March 2020

Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter

scientific article published on 10 July 2019

Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs

scientific article published on 23 July 2019

Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis

scientific article published on 25 July 2019

Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development

scientific article

Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage

scientific article published on 21 November 2014

High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C

scientific article published on 05 February 2020

Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.

scientific article published on 26 April 2017

Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria

scientific article published on 20 June 2020

Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan

scientific article published on 18 March 2020

Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease

scientific article published on 18 December 2013

Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.

scientific article published on 12 December 2016

Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19

scientific article published on 30 July 2020

Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α.

scientific article published on 12 May 2014